Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplementation and Acute Kidney Injury in Cisplatin-Treated Patients
jRCT1040240188Recruiting
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin in cancer, sponsored by none. Primary endpoint: Proportion of intravenous magnesium supplementation on day 1 of cisplatin administration. Started Feb 2025; status: recruiting.
02
Drugs
cisplatin
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT1040240188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1040240188.